Mark A. Spahr

641 total citations
14 papers, 481 citations indexed

About

Mark A. Spahr is a scholar working on Cancer Research, Surgery and Molecular Biology. According to data from OpenAlex, Mark A. Spahr has authored 14 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Mark A. Spahr's work include Lipoproteins and Cardiovascular Health (5 papers), Cancer, Lipids, and Metabolism (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Mark A. Spahr is often cited by papers focused on Lipoproteins and Cardiovascular Health (5 papers), Cancer, Lipids, and Metabolism (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Mark A. Spahr collaborates with scholars based in United States, Canada and Australia. Mark A. Spahr's co-authors include Roger S. Newton, Stephen L. Pinkosky, Rahul Srivastava, С. И. Филиппов, Timothy R. Hurley, Jeffrey C. Hanselman, Clay T. Cramer, Khosrow Adeli, Mark Naples and Jacob L. Houghton and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Arteriosclerosis Thrombosis and Vascular Biology and Journal of Lipid Research.

In The Last Decade

Mark A. Spahr

14 papers receiving 464 citations

Peers

Mark A. Spahr
Diane J. Greene United States
Susan Kühnast Netherlands
Ray Rosa United States
Michael La Belle United States
C. Dachet France
M.L. Nava United States
Diane J. Greene United States
Mark A. Spahr
Citations per year, relative to Mark A. Spahr Mark A. Spahr (= 1×) peers Diane J. Greene

Countries citing papers authored by Mark A. Spahr

Since Specialization
Citations

This map shows the geographic impact of Mark A. Spahr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Spahr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Spahr more than expected).

Fields of papers citing papers by Mark A. Spahr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Spahr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Spahr. The network helps show where Mark A. Spahr may publish in the future.

Co-authorship network of co-authors of Mark A. Spahr

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Spahr. A scholar is included among the top collaborators of Mark A. Spahr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Spahr. Mark A. Spahr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Филиппов, С. И., Stephen L. Pinkosky, Richard J. Lister, et al.. (2013). ETC-1002 regulates immune response, leukocyte homing, and adipose tissue inflammation via LKB1-dependent activation of macrophage AMPK. Journal of Lipid Research. 54(8). 2095–2108. 68 indexed citations
2.
Pinkosky, Stephen L., С. И. Филиппов, Rahul Srivastava, et al.. (2012). AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism. Journal of Lipid Research. 54(1). 134–151. 191 indexed citations
3.
Hanselman, Jeffrey C., Rai Ajit K. Srivastava, Timothy R. Hurley, et al.. (2012). Abstract 292: ETC-1002 Reduces Body Weight Gain and Hepatic Triglyceride Content and Improves Glycemic Control in a Mouse Model of Diet-Induced Obesity. Arteriosclerosis Thrombosis and Vascular Biology. 32(suppl_1). 2 indexed citations
4.
Sexton, Karen E., Helen T. Lee, Mark A. Massa, et al.. (2003). Inhibitors of lipoprotein(a) assembly. Bioorganic & Medicinal Chemistry. 11(22). 4827–4845. 6 indexed citations
5.
Bocan, Thomas, et al.. (1999). Recombinant adenovirus vector mediated expression of lipoprotein (a) [Lp(a)] in rabbit plasma. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1438(3). 322–328. 4 indexed citations
6.
Spahr, Mark A., et al.. (1998). CI-1011 lowers lipoprotein(a) and plasma cholesterol concentrations in chow-fed cynomolgus monkeys. Atherosclerosis. 136(1). 79–87. 24 indexed citations
7.
Spahr, Mark A., et al.. (1998). The Apolipoprotein(a) Promoter Contains a Retinoid Response Element. Biochemical and Biophysical Research Communications. 245(1). 194–197. 6 indexed citations
8.
Chung, Fu‐Zon, Helen T. Lee, W. Thomas Mueller, et al.. (1998). Bacterial Expression and Characterization of Human Recombinant Apolipoprotein(a) Kringle IV Type 9. Protein Expression and Purification. 13(2). 222–228. 1 indexed citations
9.
Spahr, Mark A., et al.. (1998). Dominant Negative Effect of TGF-β1 and TNF-α on Basal and IL-6–Induced Lipoprotein(a) and Apolipoprotein(a) mRNA Expression in Primary Monkey Hepatocyte Cultures. Arteriosclerosis Thrombosis and Vascular Biology. 18(6). 984–990. 78 indexed citations
10.
Spahr, Mark A., et al.. (1997). Retinoids Inhibit Primary Cynomolgus Monkey Hepatocyte Lipoprotein(a) Levels. Biochemical and Biophysical Research Communications. 238(1). 48–52. 4 indexed citations
11.
Ryan, Michael J., et al.. (1997). Localization of Lipoprotein(a) in a Monkey Model of Rapid Neointimal Growth. Arteriosclerosis Thrombosis and Vascular Biology. 17(1). 181–187. 13 indexed citations
12.
Spahr, Mark A., et al.. (1996). Expression of apolipoprotein[a] and plasminogen mRNAs in cynomolgus monkey liver and extrahepatic tissues. Journal of Lipid Research. 37(9). 2029–2040. 24 indexed citations
13.
Spahr, Mark A., et al.. (1995). Gemfibrozil significantly lowers cynomolgus monkey plasma lipoprotein[a]-protein and liver apolipoprotein[a] mRNA levels.. Journal of Lipid Research. 36(6). 1294–1304. 27 indexed citations
14.
Paine, Robert, et al.. (1991). Alveolar Epithelial Cells Block Lymphocyte Proliferation In Vitro without Inhibiting Activation. American Journal of Respiratory Cell and Molecular Biology. 5(3). 221–229. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026